Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Responses to online GSTM1 genetic test results among smokers related to patients with lung cancer: a pilot study.

Sanderson SC, O'Neill SC, White DB, Bepler G, Bastian L, Lipkus IM, McBride CM.

Cancer Epidemiol Biomarkers Prev. 2009 Jul;18(7):1953-61. doi: 10.1158/1055-9965.EPI-08-0620. Epub 2009 Jun 30.

2.
3.

Implications of Personal Genomic Testing for Health Behaviors: The Case of Smoking.

Olfson E, Hartz S, Carere DA, Green RC, Roberts JS, Bierut LJ; PGen Study Group.

Nicotine Tob Res. 2016 Dec;18(12):2273-2277. Epub 2016 Jul 12.

4.

The interaction between smoking and GSTM1 variant on lung cancer in the Chinese population.

Zhang Y, Liu C.

Tumour Biol. 2013 Feb;34(1):395-401. doi: 10.1007/s13277-012-0562-5. Epub 2012 Oct 23. Retraction in: Tumour Biol. 2017 Apr 20;:.

PMID:
23090633
5.

GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.

Schneider J, Bernges U, Philipp M, Woitowitz HJ.

Cancer Lett. 2004 May 10;208(1):65-74.

PMID:
15105047
6.

Influence of CYP1A1, GSTM1, GSTT1, and NQO1 genotypes and cumulative smoking dose on lung cancer risk in a Swedish population.

Alexandrie AK, Nyberg F, Warholm M, Rannug A.

Cancer Epidemiol Biomarkers Prev. 2004 Jun;13(6):908-14.

7.

A pilot randomised trial to assess the methods and procedures for evaluating the clinical effectiveness and cost-effectiveness of Exercise Assisted Reduction then Stop (EARS) among disadvantaged smokers.

Taylor AH, Thompson TP, Greaves CJ, Taylor RS, Green C, Warren FC, Kandiyali R, Aveyard P, Ayres R, Byng R, Campbell JL, Ussher MH, Michie S, West R.

Health Technol Assess. 2014 Jan;18(4):1-324. doi: 10.3310/hta18040.

8.

Associations between both genetic and environmental biomarkers and lung cancer: evidence of a greater risk of lung cancer in women smokers.

Tang DL, Rundle A, Warburton D, Santella RM, Tsai WY, Chiamprasert S, Hsu YZ, Perera FP.

Carcinogenesis. 1998 Nov;19(11):1949-53.

PMID:
9855008
9.

Glutathione S-transferase M1 gene polymorphism is related to COPD in patients with non-small-cell lung cancer.

Tkácová R, Salagovic J, Ceripková M, Tkác I, Stubna J, Kalina I.

Wien Klin Wochenschr. 2004 Feb 28;116(4):131-4.

PMID:
15038404
10.

Effect of nicotine replacement therapy on quitting by young adults in a trial comparing cessation services.

Buller DB, Halperin A, Severson HH, Borland R, Slater MD, Bettinghaus EP, Tinkelman D, Cutter GR, Woodall WG.

J Public Health Manag Pract. 2014 Mar-Apr;20(2):E7-E15. doi: 10.1097/PHH.0b013e3182a0b8c7.

11.

Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers.

Woodson K, Stewart C, Barrett M, Bhat NK, Virtamo J, Taylor PR, Albanes D.

Cancer Epidemiol Biomarkers Prev. 1999 Nov;8(11):965-70.

12.

Differential interactions between GSTM1 and NAT2 genotypes on aromatic DNA adduct level and HPRT mutant frequency in lung cancer patients and population controls.

Hou SM, Fält S, Yang K, Nyberg F, Pershagen G, Hemminki K, Lambert B.

Cancer Epidemiol Biomarkers Prev. 2001 Feb;10(2):133-40.

13.

Psychological and behavioural impact of genetic testing smokers for lung cancer risk: a phase II exploratory trial.

Sanderson SC, Humphries SE, Hubbart C, Hughes E, Jarvis MJ, Wardle J.

J Health Psychol. 2008 May;13(4):481-94. doi: 10.1177/1359105308088519.

PMID:
18420756
14.

Genetic susceptibility, residential radon, and lung cancer in a radon prone area.

Ruano-Ravina A, Pereyra MF, Castro MT, Pérez-Ríos M, Abal-Arca J, Barros-Dios JM.

J Thorac Oncol. 2014 Aug;9(8):1073-80. doi: 10.1097/JTO.0000000000000205.

15.

Polymorphisms in GSTM1, CYP1A1, CYP2E1, and CYP2D6 are associated with susceptibility and chemotherapy response in non-small-cell lung cancer patients.

Li W, Yue W, Zhang L, Zhao X, Ma L, Yang X, Zhang C, Wang Y, Gu M.

Lung. 2012 Feb;190(1):91-8. doi: 10.1007/s00408-011-9338-8. Epub 2011 Nov 23.

PMID:
22109568
16.

Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) polymorphisms and lung cancer risk among Northwestern Mediterraneans.

To-Figueras J, Gené M, Gómez-Catalán J, Galán MC, Fuentes M, Ramón JM, Rodamilans M, Huguet E, Corbella J.

Carcinogenesis. 1997 Aug;18(8):1529-33.

PMID:
9276626
17.

A novel approach for assessment of cancer predisposing roles of GSTM1 and GSTT1 genes: use of putatively cancer resistant elderly tumor-free smokers as the referents.

Belogubova EV, Togo AV, Karpova MB, Kuligina ESh, Buslova KG, Ulibina JM, Lemehov VG, Romanenko SM, Shutkin VA, Hanson KP, Hirvonen A, Imyanitov EN.

Lung Cancer. 2004 Mar;43(3):259-66.

PMID:
15165083
18.

Expression and polymorphism of glutathione S-transferase in human lungs: risk factors in smoking-related lung cancer.

Nakajima T, Elovaara E, Anttila S, Hirvonen A, Camus AM, Hayes JD, Ketterer B, Vainio H.

Carcinogenesis. 1995 Apr;16(4):707-11.

PMID:
7728947
19.
20.

Polymorphism of glutathione S-transferase M1 and lung cancer risk among African-Americans and Caucasians in Los Angeles County, California.

London SJ, Daly AK, Cooper J, Navidi WC, Carpenter CL, Idle JR.

J Natl Cancer Inst. 1995 Aug 16;87(16):1246-53.

PMID:
7563171

Supplemental Content

Support Center